| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | +124.6% |
| Cost of Revenue | $1.4M | -17.5% |
| Gross Profit | $94K | +109.0% |
| R&D Expense | $37.0M | -55.0% |
| SG&A Expense | $24.4M | -42.8% |
| Operating Income | -$64.3M | +53.2% |
| Income Tax | $0 | — |
| Net Income | -$52.0M | +57.9% |
| EPS (Basic) | -$0.30 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.2M | -28.4% |
| Short-term Investments | $110.9M | -26.2% |
| Accounts Receivable | $1.9M | +4707.5% |
| Current Assets | $131.0M | -27.9% |
| Total Assets | $263.0M | -19.9% |
| Current Liabilities | $14.3M | -5.5% |
| Total Liabilities | $18.7M | -15.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.7M | +51.5% |
| Capital Expenditures | $16.5M | +123.3% |
| Investing Cash Flow | $59.5M | +225.0% |
| Financing Cash Flow | -$14.3M | — |
| Free Cash Flow | -$73.3M | +41.1% |
| +55.9% |
| EPS (Diluted) | -$0.30 | +55.9% |
| Stockholders' Equity |
| $244.4M |
| -20.2% |